Blog

Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background
Slide background

Vaxinc

Vaxinc, an immunotherapy research group within the University of Southampton’s Faculty of Medicine, are pioneering a new and unique vaccination strategy that aims to deliver protection against cancer. NK cells express many different receptors and can react in a number of different ways when stimulated through one receptor. Vaxinc have discovered a new way that NK cells respond to small viral peptides, which allows them to be targeted and switched on through a simple vaccination strategy.

www.futureworlds.com/discover-vaxinc